92 related articles for article (PubMed ID: 10852770)
1. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life.
van Den BERG JW; Geertsma A; van Der BIJ W; Koëter GH; de BOER WJ; Postma DS; ten VERGERT EM
Am J Respir Crit Care Med; 2000 Jun; 161(6):1937-41. PubMed ID: 10852770
[TBL] [Abstract][Full Text] [Related]
2. The effect of bronchiolitis obliterans syndrome on health related quality of life.
Vermeulen KM; Groen H; van der Bij W; Erasmus ME; Koëter GH; TenVergert EM
Clin Transplant; 2004 Aug; 18(4):377-83. PubMed ID: 15233813
[TBL] [Abstract][Full Text] [Related]
3. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.
Gerbase MW; Soccal PM; Spiliopoulos A; Nicod LP; Rochat T
J Heart Lung Transplant; 2008 Aug; 27(8):898-904. PubMed ID: 18656804
[TBL] [Abstract][Full Text] [Related]
4. Long-term health-related quality of life after lung transplantation: different predictors for different dimensions.
Vermuelen KM; van der Bij W; Erasmus ME; TenVergert EM
J Heart Lung Transplant; 2007 Feb; 26(2):188-93. PubMed ID: 17258154
[TBL] [Abstract][Full Text] [Related]
5. Quality of life before and after lung transplantation in patients with emphysema versus other indications.
TenVergert EM; Vermeulen KM; Geertsma A; van Enckevort PJ; de Boer WJ; van der Bij W; Koëter GH
Psychol Rep; 2001 Dec; 89(3):707-17. PubMed ID: 11824741
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in two hundred-eighty lung transplant recipients.
Kugler C; Fischer S; Gottlieb J; Welte T; Simon A; Haverich A; Strueber M
J Heart Lung Transplant; 2005 Dec; 24(12):2262-8. PubMed ID: 16364880
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome after pulmonary retransplantation.
Strueber M; Fischer S; Gottlieb J; Simon AR; Goerler H; Gohrbandt B; Welte T; Haverich A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):407-12. PubMed ID: 16872970
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and bronchiolitis obliterans syndrome in patients after lung transplantation.
Künsebeck HW; Kugler C; Fischer S; Simon AR; Gottlieb J; Welte T; Haverich A; Strueber M
Prog Transplant; 2007 Jun; 17(2):136-41. PubMed ID: 17624136
[TBL] [Abstract][Full Text] [Related]
9. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
10. Long-term quality of life in patients surviving at least 55 months after lung transplantation.
Vermeulen KM; Ouwens JP; van der Bij W; de Boer WJ; Koëter GH; TenVergert EM
Gen Hosp Psychiatry; 2003; 25(2):95-102. PubMed ID: 12676422
[TBL] [Abstract][Full Text] [Related]
11. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome.
Brugière O; Thabut G; Mal H; Marceau A; Dauriat G; Marrash-Chahla R; Castier Y; Lesèche G; Colombat M; Fournier M
Eur Respir J; 2005 May; 25(5):813-9. PubMed ID: 15863637
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
[TBL] [Abstract][Full Text] [Related]
13. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
[TBL] [Abstract][Full Text] [Related]
14. The effect of lung transplantation on health-related quality of life: a longitudinal study.
TenVergert EM; Essink-Bot ML; Geertsma A; van Enckevort PJ; de Boer WJ; van der Bij W
Chest; 1998 Feb; 113(2):358-64. PubMed ID: 9498952
[TBL] [Abstract][Full Text] [Related]
15. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
16. Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation.
Walter JN; Fan LL; Bag R; Zhang H; Doan M; Mallory GB; Elidemir O
Transplantation; 2006 Sep; 82(5):709-11. PubMed ID: 16969297
[TBL] [Abstract][Full Text] [Related]
17. Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation.
Budding K; van de Graaf EA; Paantjens AW; Kardol-Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Otten HG
Transpl Immunol; 2015 Jun; 32(3):195-200. PubMed ID: 25841614
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
19. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
20. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
